| Mean number (SD) of days of work missed per week at trial beginning | Mean number (SD) of days of work missed per week at trial end | Statistical significance |
---|---|---|---|
Pregabalin dose (n) | Â | Â | Â |
Placebo (557) | 2.2 (2.3) | 1.9 (2.1) | ** |
300 mg (547) | 2.4 (2.3) | 1.9 (2.1) | **** |
450 mg (553) | 2.1 (2.2) | 1.7 (2.0) | *** |
600 mg (561) | 2.1 (2.2) | 1.6 (2.0) | *** |
Pain improvement (n) | Â | Â | Â |
Pain worse (221) | 1.9 (2.1) | 1.9 (2.1) | NS |
0-15% (281) | 2.5 (2.4) | 2.2 (2.2) | NS |
15-30% (233) | 2.4 (2.2) | 1.7 (2.0) | *** |
30-50% (319) | 2.1 (2.2) | 1.1 (1.7) | **** |
≥50% (435) | 2.0 (2.2) | 0.97 (1.6) | **** |
VAS pain score at trial end (n) | Â | Â | Â |
>50 mm (1042) | 2.4 (2.3) | 2.1 (2.1) | * |
>30-50 mm (340) | 1.9 (2.0) | 1.1 (1.7) | **** |
0-30 mm (436) | 1.9 (2.2) | 0.73 (1.4) | **** |